Characterization of the secondary neutron field produced during treatment of an anthropomorphic phantom with x-rays, protons and carbon ions
Authors:
- C La TessaCTC La Tessa
- T BergerTBT Berger
- R KaderkaRKR Kaderka
- D SchardtDSD Schardt
- S BurmeisterSBS Burmeister
- J LabrenzJLJ Labrenz
- G ReitzGRG Reitz
- M DuranteM Durante
- 2 April 2014
- journal article
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 59 (8) , 2111-2125
Abstract
Short- and long-term side effects following the treatment of cancer with radiation are strongly related to the amount of dose deposited to the healthy tissue surrounding the tumor. The characterization of the radiation field outside the planned target volume is the first step for estimating health risks, such as developing a secondary radioinduced malignancy. In ion and high-energy photon treatments, the major contribution to the dose deposited in the far-out-of-field region is given by neutrons, which are produced by nuclear interaction of the primary radiation with the beam line components and the patient's body. Measurements of the secondary neutron field and its contribution to the absorbed dose and equivalent dose for different radiotherapy technologies are presented in this work. An anthropomorphic RANDO phantom was irradiated with a treatment plan designed for a simulated 5 × 2 × 5 cm³ cancer volume located in the center of the head. The experiment was repeated with 25 MV IMRT (intensity modulated radiation therapy) photons and charged particles (protons and carbon ions) delivered with both passive modulation and spot scanning in different facilities. The measurements were performed with active (silicon-scintillation) and passive (bubble, thermoluminescence ⁶LiF:Mg, Ti (TLD-600) and ⁷LiF:Mg, Ti (TLD-700)) detectors to investigate the production of neutral particles both inside and outside the phantom. These techniques provided the whole energy spectrum (E ≤ 20 MeV) and corresponding absorbed dose and dose equivalent of photo neutrons produced by x-rays, the fluence of thermal neutrons for all irradiation types and the absorbed dose deposited by neutrons with 0.8 < E < 10 MeV during the treatment with scanned carbon ions. The highest yield of thermal neutrons is observed for photons and, among ions, for passively modulated beams. For the treatment with high-energy x-rays, the contribution of secondary neutrons to the dose equivalent is of the same order of magnitude as the primary radiation. In carbon therapy delivered with raster scanning, the absorbed dose deposited by neutrons in the energy region between 0.8 and 10 MeV is almost two orders of magnitude lower than charged fragments. We conclude that, within the energy range explored in this experimental work, the out-of-field dose from secondary neutrons is lowest for ions delivered by scanning, followed by passive modulation, and finally by high-energy IMRT photons.Keywords
This publication has 24 references indexed in Scilit:
- Second cancer after radiotherapy, 1981–2007Radiotherapy and Oncology, 2012
- Out-of-field dose measurements in a water phantom using different radiotherapy modalitiesPhysics in Medicine & Biology, 2012
- Out-of-field dose studies with an anthropomorphic phantom: Comparison of X-rays and particle therapy treatmentsRadiotherapy and Oncology, 2012
- Assessing the risk of second malignancies after modern radiotherapyNature Reviews Cancer, 2011
- Methodology for determining doses to in-field, out-of-field and partially in-field organs for late effects studies in photon radiotherapyPhysics in Medicine & Biology, 2010
- Charged particles in radiation oncologyNature Reviews Clinical Oncology, 2009
- Secondary neutron spectra from modern Varian, Siemens, and Elekta linacs with multileaf collimatorsMedical Physics, 2009
- TL-efficiency—Overview and experimental results over the yearsRadiation Measurements, 2008
- Fast neutrons produced by nuclear fragmentation in treatment irradiations with 12C beamRadiation Protection Dosimetry, 2004
- Quality of Life End Points in Cancer Clinical Trials: Review and RecommendationsJNCI: Journal of the National Cancer Institute, 1989